Kimberly-Clark stock gets new growth and customer chiefs
Published on 11/20/2026 at 22:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLeadership changes target growth
- Katie Devine will lead Kimberly-Clark's global growth, innovation, analytics and research organization.
- Brian Giroux will oversee commercial transformation, customer development and trade optimization.
- Chief Research and Development Officer Craig Slavtcheff is set to leave after a transition in January.
Kimberly-Clark announced two executive appointments on November 19, 2026, naming Katie Devine Chief Growth and Innovation Officer and Brian Giroux Chief Customer Officer. Both will join the company's Enterprise Leadership Team and report to Chairman and Chief Executive Officer Mike Hsu, according to the Kimberly-Clark release carried by PR Newswire.
New leaders target expansion
Devine will unite category strategy and innovation in a centralized global growth organization covering sector leadership, analytics and research and development. She brings more than 25 years of experience across consumer health, pharmaceuticals, corporate strategy and veterinary health, including senior roles at Johnson and Johnson and Mars Science and Diagnostics.
Giroux will lead the company's global commercial transformation and trade optimization agenda. His remit includes revenue growth management, commercial spending optimization and sales execution. Giroux previously held senior leadership roles at Kimberly-Clark and spent 28 years at Kraft Foods Group.
Execution becomes the investor test
The appointments give Kimberly-Clark dedicated leadership for growth initiatives and customer execution as the company expands its consumer health portfolio. In connection with Devine's appointment, Chief Research and Development Officer Craig Slavtcheff will leave the company after a transition in January.
Kimberly-Clark stock traded at 96.88 euros on Lang & Schwarz at 22:48 CET on Friday, November 20.
Kimberly-Clark Corporation
- ISIN: US4943681035
- Ticker: KMB
- Primary exchange: Nasdaq
- Lang and Schwarz quote: 96.88 euros on November 20, 2026, at 22:48 CET
The appointments come as Kimberly-Clark builds its global health and wellness business across more than 175 countries. The company says its portfolio includes brands such as Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex and Scott.
The S&P 500 market environment provides the broader benchmark for the US-listed company.
